BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17072461)

  • 1. Protection against hepatitis B by the Butang recombinant vaccine in newborn children in South Brazil.
    Isolani AP; Sversuti CS; Sell AM; Moliterno RA
    Mem Inst Oswaldo Cruz; 2006 Aug; 101(5):551-3. PubMed ID: 17072461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
    Martins RM; Bensabath G; Arraes LC; Oliveira Mde L; Miguel JC; Barbosa GG; Camacho LA
    Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):865-71. PubMed ID: 15761604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
    Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
    Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.
    Oliveira MD; Martins RM; Matos MA; Ferreira RC; Dias MA; Carneiro MA; Junqueira AL; Teles SA
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):251-6. PubMed ID: 16862317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The long-term efficacy of a recombinant hepatitis B vaccine in newborns].
    Tejedor Torres JC; Reyes Pecharromán S; Pérez Rivilla A; Sayalero Martín M; Aybar Garciá L; Sánchez de León L; Puyol Buil P
    An Esp Pediatr; 1993 Sep; 39(3):243-7. PubMed ID: 8250440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of serological status of children following hepatitis B vaccination during infancy].
    Süleyman A; Gökçay G; Badur S; Aykın S; Kılıç G; Tamay Z; Unüvar E; Güler N
    Mikrobiyol Bul; 2012 Jan; 46(1):47-56. PubMed ID: 22399171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response in infants after universal high-dose hepatitis B vaccination: A community-based study in Beijing, China.
    Xiao M; Qiu Q; Pang X; Liang X; Li L; Cui F; Wang F; Zhang G; Li H; Wang L; Zhang W
    Vaccine; 2015 Oct; 33(43):5878-5883. PubMed ID: 26117148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
    Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
    Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
    Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
    Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
    Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
    Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.